MRK
Merck & Co., Inc.Company with tickers: MRK
CIK
310158
CUSIP
58933Y105
Shares Outstanding
2,469,824,415
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $15,529,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,621,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Operating Income | — | ||||
| Net Income | $5,079,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $2.01 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $2.01 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |